ATE355266T1 - Neue acylierte pseudodipeptide, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen - Google Patents
Neue acylierte pseudodipeptide, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungenInfo
- Publication number
- ATE355266T1 ATE355266T1 AT99957636T AT99957636T ATE355266T1 AT E355266 T1 ATE355266 T1 AT E355266T1 AT 99957636 T AT99957636 T AT 99957636T AT 99957636 T AT99957636 T AT 99957636T AT E355266 T1 ATE355266 T1 AT E355266T1
- Authority
- AT
- Austria
- Prior art keywords
- production
- pharmaceutical compositions
- compositions containing
- containing same
- new acylated
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/10—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9801396 | 1998-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE355266T1 true ATE355266T1 (de) | 2006-03-15 |
Family
ID=9522667
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99957636T ATE355266T1 (de) | 1998-06-30 | 1999-06-23 | Neue acylierte pseudodipeptide, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen |
Country Status (21)
Country | Link |
---|---|
US (2) | US7157092B1 (de) |
EP (1) | EP1091928B1 (de) |
JP (1) | JP4699609B2 (de) |
KR (1) | KR100766016B1 (de) |
CN (1) | CN1168702C (de) |
AR (1) | AR029877A1 (de) |
AT (1) | ATE355266T1 (de) |
AU (1) | AU761396B2 (de) |
BR (1) | BR9911329A (de) |
CA (1) | CA2337807C (de) |
CZ (1) | CZ302062B6 (de) |
DE (1) | DE69935330T2 (de) |
DK (1) | DK1091928T3 (de) |
EE (1) | EE04489B1 (de) |
ES (1) | ES2284275T3 (de) |
HU (1) | HUP0102475A3 (de) |
PL (1) | PL195764B1 (de) |
RU (1) | RU2223262C2 (de) |
SK (1) | SK287073B6 (de) |
TW (1) | TWI255808B (de) |
WO (1) | WO2000000462A1 (de) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EE04489B1 (et) * | 1998-06-30 | 2005-06-15 | Om Pharma | Atsüülpseudodipeptiidid, nende valmistamise meetod ja neid sisaldavad farmatseutilised kompositsioonid |
WO2001046127A1 (fr) * | 1999-12-22 | 2001-06-28 | Om Pharma | Pseudodipeptides acyles porteurs d'un bras auxiliaire fonctionnalise |
WO2002064616A2 (en) * | 2001-01-30 | 2002-08-22 | University Of Virgina Patent Foundation | Agonists and antagonists of sphingosine-1-phosphate receptors |
ES2335979T3 (es) | 2001-09-14 | 2010-04-07 | Cytos Biotechnology Ag | Empaquetamiento de cpg inmunoestimuladores en particulas similares a virus: metodo de preparacion y su uso. |
NZ537003A (en) | 2002-07-18 | 2008-03-28 | Cytos Biotechnology Ag | Hapten-carrier conjugates comprising virus like particles and uses thereof |
US7517520B2 (en) | 2003-03-26 | 2009-04-14 | Cytos Biotechnology Ag | Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use |
EP2269638A3 (de) | 2004-05-28 | 2012-06-13 | GlaxoSmithKline Biologicals S.A. | Impfstoffzusammensetzungen mit Virosomen und einem Saponin-Adjuvans |
GB0503337D0 (en) | 2005-02-17 | 2005-03-23 | Glaxosmithkline Biolog Sa | Compositions |
AU2006226458B2 (en) | 2005-03-23 | 2012-08-30 | Glaxosmithkline Biologicals S.A. | Novel composition |
JP5484732B2 (ja) | 2005-12-14 | 2014-05-07 | サイトス バイオテクノロジー アーゲー | 過敏症の治療のための免疫賦活性核酸パッケージ粒子 |
EP3470080A1 (de) | 2005-12-22 | 2019-04-17 | GlaxoSmithKline Biologicals S.A. | Impfstoff |
GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
WO2007102081A2 (en) | 2006-03-09 | 2007-09-13 | Om Pharma | Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines |
EP2476433A1 (de) | 2006-03-30 | 2012-07-18 | GlaxoSmithKline Biologicals S.A. | Immunogene Zusammensetzung |
PL2032592T3 (pl) | 2006-06-12 | 2013-11-29 | Kuros Biosciences Ag | Sposoby pakowania oligonukleotydów do cząstek wirusopodobnych z bakteriofagów RNA |
EP2040742B1 (de) | 2006-07-18 | 2014-10-29 | GlaxoSmithKline Biologicals S.A. | Malaria-impfstoffe |
WO2008012538A2 (en) | 2006-07-25 | 2008-01-31 | The Secretary Of State For Defence | Live vaccine strains of francisella |
US20090263422A1 (en) | 2006-09-15 | 2009-10-22 | Emmanuel Jules Hanon | Influenza vaccine |
EP2086582B1 (de) | 2006-10-12 | 2012-11-14 | GlaxoSmithKline Biologicals s.a. | Impfstoff mit einem öl-in-wasser-emulsionshilfsstoff |
CN101675068A (zh) | 2007-03-02 | 2010-03-17 | 葛兰素史密丝克莱恩生物有限公司 | 新的方法和组合物 |
AR066405A1 (es) | 2007-04-20 | 2009-08-19 | Glaxosmithkline Biolog Sa | Vacuna |
KR20100045445A (ko) | 2007-06-26 | 2010-05-03 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 스트렙토코쿠스 뉴모니애 캡슐 다당류 컨쥬게이트를 포함하는 백신 |
EP2020240A1 (de) * | 2007-07-30 | 2009-02-04 | Paul-Ehrlich-Institut Bundesamt für Sera und Impfstoffe | Verfahren und Substanzen zur Behandlung von Morbus Alzheimer |
EP2227483B1 (de) | 2007-12-19 | 2017-04-19 | The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | Lösliche formen von hendra- und nipah-virus-f-glycoprotein und anwendungen davon |
CN101952321B (zh) | 2007-12-24 | 2016-05-11 | 葛兰素史密斯克莱生物公司 | 重组rsv抗原 |
SI2271360T1 (sl) | 2008-04-16 | 2015-12-31 | Glaxosmithkline Biologicals S.A. | Cepivo |
CN102325790A (zh) | 2008-12-03 | 2012-01-18 | 西马生物医学计划公司 | 应用酚可溶性调控蛋白研制疫苗 |
WO2010079081A1 (en) | 2009-01-07 | 2010-07-15 | Glaxosmithkline Biologicals S.A. | Methods for recovering a virus or a viral antigen produced by cell culture |
GB0901423D0 (en) | 2009-01-29 | 2009-03-11 | Secr Defence | Treatment |
GB0901411D0 (en) | 2009-01-29 | 2009-03-11 | Secr Defence | Treatment |
JP5843615B2 (ja) | 2009-02-06 | 2016-01-13 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 密度勾配超遠心分離によるウイルスまたはウイルス抗原の精製 |
SG2014014385A (en) | 2009-02-17 | 2014-04-28 | Glaxosmithkline Biolog Sa | Inactivated dengue virus vaccine with aluminium-free adjuvant |
GB0906234D0 (en) | 2009-04-14 | 2009-05-20 | Secr Defence | Vaccine |
CA2766205A1 (en) | 2009-06-24 | 2010-12-29 | Id Biomedical Corporation Of Quebec | Vaccine comprising at least two paramyxovirus f protein antigens |
PE20121541A1 (es) | 2009-06-24 | 2012-12-21 | Glaxosmithkline Biolog Sa | Antigenos de virus de sincicio respiratorio recombinantes |
PL3178490T3 (pl) | 2009-07-15 | 2022-08-01 | Glaxosmithkline Biologicals S.A. | Kompozycje białka f rsv i sposoby ich wytwarzania |
GB0913680D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
ES2538474T3 (es) | 2009-09-25 | 2015-06-22 | Glaxosmithkline Biologicals S.A. | Ensayo de inmunodifusión para el virus de la gripe |
GB0919117D0 (en) | 2009-10-30 | 2009-12-16 | Glaxosmithkline Biolog Sa | Process |
WO2011101332A1 (en) | 2010-02-16 | 2011-08-25 | Proyecto De Biomedicina Cima, S.L. | Compositions based on the fibronectin extracellular domain a for the treatment of melanoma |
JP6200805B2 (ja) | 2010-05-03 | 2017-09-20 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 新規な方法 |
GB201009273D0 (en) | 2010-06-03 | 2010-07-21 | Glaxosmithkline Biolog Sa | Novel vaccine |
SG189176A1 (en) | 2010-10-15 | 2013-05-31 | Glaxosmithkline Biolog Sa | Cytomegalovirus gb antigen |
EP2505640A1 (de) | 2011-03-29 | 2012-10-03 | Neo Virnatech, S.L. | Impfstoffzusammensetzungen für vom Birnavirus übertragenen Krankheiten |
MX339058B (es) | 2011-05-17 | 2016-05-09 | Glaxosmithkline Biolog Sa | Vacuna contra streptococcus pneumoniae. |
BR112014023092A8 (pt) | 2012-03-18 | 2017-07-25 | Glaxosmithkline Biologicals Sa | Composição imunogênica, método para a prevenção de infecção ou doença por hpv em um indivíduo, e, kit |
SG11201500573RA (en) | 2012-08-06 | 2015-02-27 | Glaxosmithkline Biolog Sa | Method for eliciting in infants an immune response against rsv and b. pertussis |
US20140037680A1 (en) | 2012-08-06 | 2014-02-06 | Glaxosmithkline Biologicals, S.A. | Novel method |
AR095425A1 (es) | 2013-03-15 | 2015-10-14 | Glaxosmithkline Biologicals Sa | Vacuna, uso y procedimiento para prevenir una infección por picornavirus |
WO2015011254A1 (en) | 2013-07-26 | 2015-01-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of bacterial infections |
WO2015018806A1 (en) | 2013-08-05 | 2015-02-12 | Glaxosmithkline Biologicals S.A. | Combination immunogenic compositions |
ES2778928T3 (es) | 2013-08-30 | 2020-08-12 | Glaxosmithkline Biologicals Sa | Producción a gran escala de virus en cultivos celulares |
CN104436157A (zh) | 2013-09-23 | 2015-03-25 | 恩金生物有限公司 | 流感疫苗和治疗 |
WO2015130584A2 (en) | 2014-02-25 | 2015-09-03 | Merck Sharp & Dohme Corp. | Lipid nanoparticle vaccine adjuvants and antigen delivery systems |
WO2015165480A1 (en) | 2014-04-30 | 2015-11-05 | Institute For Research In Biomedicine | Human cytomegalovirus vaccine compositions and method of producing the same |
JP6664338B2 (ja) | 2014-06-13 | 2020-03-13 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 免疫原性組合せ物 |
WO2016180852A1 (en) | 2015-05-12 | 2016-11-17 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for preparing antigen-specific t cells from an umbilical cord blood sample |
EP3313435A1 (de) | 2015-06-26 | 2018-05-02 | Institute for Research in Biomedicine | Neuartige impfstoffe zur prävention und behandlung von malaria |
GB201614799D0 (en) | 2016-09-01 | 2016-10-19 | Glaxosmithkline Biologicals Sa | Compositions |
WO2018162450A1 (en) | 2017-03-06 | 2018-09-13 | Fundación Para La Investigación Médica Aplicada | New inmunostimulatory compositions comprising an entity of cold inducible rna-binding protein with an antigen for the activation of dendritic cells |
EP3581201A1 (de) | 2018-06-15 | 2019-12-18 | GlaxoSmithKline Biologicals S.A. | Escherichia coli o157:h7 polypeptide und verwendungen davon |
US11911553B2 (en) * | 2018-07-06 | 2024-02-27 | Fenwal, Inc. | Systems and methods for concentrating cells with a syringe and a centrifuge |
WO2021014385A1 (en) | 2019-07-24 | 2021-01-28 | Glaxosmithkline Biologicals Sa | Modified human cytomegalovirus proteins |
CN112329267B (zh) * | 2020-11-26 | 2022-08-16 | 中国核动力研究设计院 | 一种基于特征线法的组合几何中子输运处理方法及装置 |
MX2023006320A (es) | 2020-12-02 | 2023-06-14 | Glaxosmithkline Biologicals Sa | Cadena donante complementada fimh. |
WO2022161598A1 (en) | 2021-01-26 | 2022-08-04 | Eth Zurich | Antibodies broadly targeting coronaviruses and uses thereof |
WO2022162012A2 (en) | 2021-01-26 | 2022-08-04 | Eth Zurich | Antibodies broadly targeting coronaviruses and uses thereof |
WO2023144665A1 (en) | 2022-01-28 | 2023-08-03 | Glaxosmithkline Biologicals Sa | Modified human cytomegalovirus proteins |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61227586A (ja) * | 1985-03-30 | 1986-10-09 | Dai Ichi Seiyaku Co Ltd | ジサツカライド誘導体およびその塩 |
US4746742A (en) * | 1985-11-28 | 1988-05-24 | Toho Yakuhin Kogyo Kabushiki Kaisha | Analogs of nonreducing monosaccharide moiety of lipid A |
DE4229877C2 (de) * | 1992-09-04 | 1994-09-15 | Max Delbrueck Centrum | Phospho- bzw. Phosphono-(N-acyl)-serine und ihre Herstellung |
EP0668289A4 (de) * | 1993-09-07 | 1998-10-21 | Suntory Ltd | Disaccharid derivate. |
BR9408071A (pt) * | 1993-11-17 | 1996-12-24 | Om Lab Sa | Di-sacarideos de glucosamina processo para sua preparação e composição farmacêutica que compreende os mesmos e seu uso |
EE04489B1 (et) * | 1998-06-30 | 2005-06-15 | Om Pharma | Atsüülpseudodipeptiidid, nende valmistamise meetod ja neid sisaldavad farmatseutilised kompositsioonid |
-
1999
- 1999-06-23 EE EEP200000791A patent/EE04489B1/xx not_active IP Right Cessation
- 1999-06-23 CA CA2337807A patent/CA2337807C/fr not_active Expired - Fee Related
- 1999-06-23 US US09/720,045 patent/US7157092B1/en not_active Expired - Fee Related
- 1999-06-23 CN CNB998077615A patent/CN1168702C/zh not_active Expired - Fee Related
- 1999-06-23 AT AT99957636T patent/ATE355266T1/de not_active IP Right Cessation
- 1999-06-23 DK DK99957636T patent/DK1091928T3/da active
- 1999-06-23 BR BR9911329-5A patent/BR9911329A/pt not_active Application Discontinuation
- 1999-06-23 SK SK1887-2000A patent/SK287073B6/sk not_active IP Right Cessation
- 1999-06-23 AU AU42848/99A patent/AU761396B2/en not_active Ceased
- 1999-06-23 ES ES99957636T patent/ES2284275T3/es not_active Expired - Lifetime
- 1999-06-23 HU HU0102475A patent/HUP0102475A3/hu unknown
- 1999-06-23 KR KR1020007015066A patent/KR100766016B1/ko not_active IP Right Cessation
- 1999-06-23 JP JP2000557223A patent/JP4699609B2/ja not_active Expired - Fee Related
- 1999-06-23 EP EP99957636A patent/EP1091928B1/de not_active Expired - Lifetime
- 1999-06-23 CZ CZ20004893A patent/CZ302062B6/cs not_active IP Right Cessation
- 1999-06-23 DE DE69935330T patent/DE69935330T2/de not_active Expired - Lifetime
- 1999-06-23 WO PCT/IB1999/001170 patent/WO2000000462A1/fr active IP Right Grant
- 1999-06-23 RU RU2001102614/04A patent/RU2223262C2/ru not_active IP Right Cessation
- 1999-06-23 PL PL99345040A patent/PL195764B1/pl not_active IP Right Cessation
- 1999-06-30 AR ARP990103172A patent/AR029877A1/es active IP Right Grant
- 1999-07-30 TW TW088112968A patent/TWI255808B/zh not_active IP Right Cessation
-
2006
- 2006-02-28 US US11/363,691 patent/US20060148678A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PL345040A1 (en) | 2001-11-19 |
EE04489B1 (et) | 2005-06-15 |
BR9911329A (pt) | 2001-10-16 |
JP2002519338A (ja) | 2002-07-02 |
CA2337807C (fr) | 2012-08-21 |
AU4284899A (en) | 2000-01-17 |
DE69935330D1 (de) | 2007-04-12 |
US20060148678A1 (en) | 2006-07-06 |
CZ20004893A3 (en) | 2001-05-16 |
EP1091928B1 (de) | 2007-02-28 |
HUP0102475A3 (en) | 2001-12-28 |
AR029877A1 (es) | 2003-07-23 |
KR100766016B1 (ko) | 2007-10-11 |
CN1168702C (zh) | 2004-09-29 |
US7157092B1 (en) | 2007-01-02 |
SK18872000A3 (sk) | 2001-07-10 |
CA2337807A1 (fr) | 2000-01-06 |
HUP0102475A2 (hu) | 2001-11-28 |
TWI255808B (en) | 2006-06-01 |
DE69935330T2 (de) | 2007-10-31 |
KR20010083078A (ko) | 2001-08-31 |
WO2000000462A1 (fr) | 2000-01-06 |
CN1306504A (zh) | 2001-08-01 |
CZ302062B6 (cs) | 2010-09-22 |
DK1091928T3 (da) | 2007-07-23 |
ES2284275T3 (es) | 2007-11-01 |
EP1091928A1 (de) | 2001-04-18 |
PL195764B1 (pl) | 2007-10-31 |
RU2223262C2 (ru) | 2004-02-10 |
SK287073B6 (sk) | 2009-11-05 |
AU761396B2 (en) | 2003-06-05 |
EE200000791A (et) | 2002-02-15 |
JP4699609B2 (ja) | 2011-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE355266T1 (de) | Neue acylierte pseudodipeptide, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen | |
DE69902535D1 (de) | Phenoxypropanolamin-derivate, verfahren zu ihrer herstellung und diese enthaltenden pharmazeutischen zusammensetzungen | |
ATE296823T1 (de) | Substituierte heterocyclische verbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
ATE252562T1 (de) | Pyrazolcarbonsäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
ATE235507T1 (de) | Neue aminosäurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
ATE234291T1 (de) | Metallproteinasehemmer, diesen enthaltende pharmazeutische zusammensetzung und dessen pharmazeutische verwendung und verfahren zu ihrer herstellung | |
ATE219069T1 (de) | Neue arylglycinamidderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
ATE279392T1 (de) | Indol-verbindungen, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und ihre medizinische anwendung | |
DE69625923D1 (de) | Oxidmaterialien, verfahren zur dessen herstellung und diese materialien enthaltende katalysatorzusammensetzungen | |
ATE252542T1 (de) | Benzolderivate, ein verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen,die diese enthalten | |
ATE323092T1 (de) | Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
ATE209219T1 (de) | Synthetische polysaccharide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
ATE143010T1 (de) | Pyridazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
DE69933307D1 (de) | Fliessfähige, wässrige borhaltige zusammensetzungen und verfahren zu ihrer herstellung | |
ATE222586T1 (de) | Benzolsulfonamidderivate und verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
DE60010113D1 (de) | N-guanidinalkylamide, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate | |
ATE313524T1 (de) | 1,1- and 1,2-disubstituierte cyclopropane, verfahren zu deren herstellung und deren pharmazeutischen zusammensetzungen | |
DE60022890D1 (de) | Naphthyridine derivate, verfahren zu ihrer herstellung, deren anwendung und sie enthaltende pharmazeutische zusammensetzungen | |
ATE244246T1 (de) | Pyridothienodiazepine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
DE69808793D1 (de) | Pharmazeutische zusammensetzungen aus dalfopristine und quinupristine und verfahren zu ihrer herstellung | |
DE59909123D1 (de) | Neue antiestrogene, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung | |
DE60200041D1 (de) | Indenoindolon-Derivate, Verfahren zu ihrer Herstellung und die enthaltenden pharmazeutischen Zusammensetzungen | |
DE69630873D1 (de) | Propylen-1-penten copolymerisate, verfahren zu deren herstellung und zusammensetzungen diese enthaltend | |
DE60013418D1 (de) | Morpholinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
DE69421182D1 (de) | Neue clathrat-verbindungen, verfahren zu ihrer herstellung und fäulmisverhinderndes mittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |